Cargando…

Clinical and molecular stratification of disease risk in medulloblastoma

The accurate assessment of disease risk among children with medulloblastoma remains a major challenge to the field of paediatric neuro-oncology. In the current study we investigated the capacity of molecular abnormalities to increase the accuracy of disease risk stratification above that afforded by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilbertson, R, Wickramasinghe, C, Hernan, R, Balaji, V, Hunt, D, Jones-Wallace, D, Crolla, J, Perry, R, Lunec, J, Pearson, A, Ellison, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364121/ https://www.ncbi.nlm.nih.gov/pubmed/11531256 http://dx.doi.org/10.1054/bjoc.2001.1987

Ejemplares similares

Genetic abnormalities detected in ependymomas by comparative genomic hybridisation
por: Carter, M, et al.
Publicado: (2002)

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
por: Gilbertson, R. J., et al.
Publicado: (1995)

Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011)

Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
por: Cho, Hee Won, et al.
Publicado: (2022)

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma
por: Lindsey, J C, et al.
Publicado: (2007)

Dual and opposing roles of primary cilia in medulloblastoma development
por: Han, Young-Goo, et al.
Publicado: (2009)

Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma
por: Taylor, C P F, et al.
Publicado: (2000)

MEDB-71. Molecular characterisation of group 4 medulloblastoma improves risk-stratification and its biological understanding
por: Goddard, Jack, et al.
Publicado: (2022)

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
por: Menyhárt, Otília, et al.
Publicado: (2020)

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
por: Goddard, Jack, et al.
Publicado: (2023)

Medulloblastoma in the Molecular Era
por: Miranda Kuzan-Fischer, Claudia, et al.
Publicado: (2018)

Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway
por: Kögel, D, et al.
Publicado: (2001)

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
por: Boland, I, et al.
Publicado: (1999)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012)

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
por: Jaros, E., et al.
Publicado: (1993)

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67
por: Tut, V M, et al.
Publicado: (2001)

CT angiographic radiomics signature for risk stratification in anterior large vessel occlusion stroke
por: Avery, Emily W., et al.
Publicado: (2022)

Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
por: Kishima, H, et al.
Publicado: (1999)

Stratification of MDD and GAD patients by resting state brain connectivity predicts cognitive bias
por: Bijsterbosch, Janine D., et al.
Publicado: (2018)

MPC-08 Molecular risk stratification using genome-wide DNA methylation data of standard-risk medulloblastomas treated with 18-Gy craniospinal irradiation
por: Irikura, Tomoya, et al.
Publicado: (2020)

Towards a tractography-based risk stratification model for language area associated gliomas
por: Tuncer, Mehmet Salih, et al.
Publicado: (2020)

MBCL-06. RISK STRATIFICATION IMPROVEMENT OF THE HIT2000 AND I-HIT-MED COHORTS USING MOLECULAR SUBTYPES I-VIII OF GROUP 3/4 MEDULLOBLASTOMAS
por: Mynarek, Martin, et al.
Publicado: (2020)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
por: Kawauchi, D, et al.
Publicado: (2017)

Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies
por: DeSouza, Ruth-Mary, et al.
Publicado: (2014)

Comparison of anatomical-based vs. nTMS-based risk stratification model for predicting postoperative motor outcome and extent of resection in brain tumor surgery
por: Ivren, Meltem, et al.
Publicado: (2023)

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
por: Mynarek, Martin, et al.
Publicado: (2022)

Stratification of the risk of bipolar disorder recurrences in pregnancy and postpartum
por: Di Florio, Arianna, et al.
Publicado: (2018)

Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project
por: Rosberg, Victoria, et al.
Publicado: (2022)

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
por: Kumar, Rahul, et al.
Publicado: (2021)

Molecular variants and mutations in medulloblastoma
por: Schroeder, Kristin, et al.
Publicado: (2014)

Proteomic profiling of high risk medulloblastoma reveals functional biology
por: Staal, Jerome A., et al.
Publicado: (2015)

Subtypes of medulloblastoma have distinct developmental origins
por: Gibson, Paul, et al.
Publicado: (2010)

Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
por: McGuigan, C, et al.
Publicado: (2016)

EMBR-25. GENOME-WIDE GENETIC AND EPIGENETIC ASSESSMENT OF GROUP 4 MEDULLOBLASTOMA FOR IMPROVED, BIOMARKER DRIVEN, PROGNOSTICATION AND RISK-STRATIFICATION
por: Goddard, Jack, et al.
Publicado: (2021)

ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma
por: Ingram, Wendy J, et al.
Publicado: (2013)

Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife
por: Rajah, M.N., et al.
Publicado: (2017)

Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
por: Korshunov, Andrey, et al.
Publicado: (2022)

Medulloblastoma with Excessive Nodularity: Radiographic Features and Pathologic Correlate
por: Yeh-Nayre, L. A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_brf2ar25j4gq95eo08o55as17m